ArticleTechnology in cancer research & treatment

MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.

Zhuanghua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.